Juliet Thompson
CIK: 0001715258
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)1 (33.3%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
INDV
Indivior Pharmaceuticals, Inc.
Director
Discretionary Trading P&L
Holdings
About Thompson Juliet
Thompson Juliet (SEC CIK 0001715258) files insider reports with the SEC as Director of Indivior Pharmaceuticals, Inc. (INDV).
Signal8 holds 3 ownership filings by Thompson Juliet (1 Form 3, 2 Form 4), filed between Jan 7, 2026 and May 14, 2026. Those filings report 3 transactions, from Jan 26, 2026 to May 13, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Thompson Juliet's filings is in NORTH CHESTERFIELD, VA.
Recent filings by Thompson Juliet
Other insiders filing for Indivior Pharmaceuticals, Inc. (INDV)
- Anderson Woodrow D, Chief Accounting Officer
- Heidbreder Christian, Chief Scientific Officer
- Ciaffoni Joseph, Chief Executive Officer
- Preblick Ryan, Chief Financial Officer
- Humphreys Keith, Director
- Kingsley Stuart A, Director